Pelthos Therapeutics revises non-employee director compensation, increases Chairman cash retainer to $60k

Pelthos Therapeutics Inc.

Non-Executive Chairman annual cash retainer increased from $50k to $60k, effective January 1, 2026.
New annual cash retainers for committee service: Audit Chair $19k, Compensation Chair $15k, Nominating Chair $12k.
Board member annual cash retainer unchanged at $40k; no annual equity grants to non-employee directors.
Changes based on compensation committee assessment to align with peer group practices.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.